A PHASE 3, OPEN-LABEL, SAFETY AND TOLERABILITY STUDY OF NBI-98854 FOR THE TREATMENT OF TARDIVE DYSKINESIA

Registry ID

NBI-98854-1402

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

NEUROCRINE BIOSCIENCES INC

Start date

2015-10-01

Completion date

2017-03-01

Last update

2015-07-28

Conditions

• TARDIVE DYSKINESIA

View on source registry